Future Medicine Ltd has today announced the launch of the new journal Hepatic Oncology. This new title focuses specifically on the specialism of hepatic cancer, including both primary and secondary malignancies. Hepatic Oncology is published by Future Medicine Ltd (part of theFuture Science Group), and joins its portfolio of oncology journals providing healthcare practitioners and research professionals with a unique source of objective, cutting-edge information on exciting trends emerging in light of advances in medicine, healthcare and clinical practice.
The direction of the journal is led by a team of three Senior Editors, Dr Jordi Bruix (University of Barcelona), Professor Richard Finn (UCLA) and Professor Ronnie TP Poon (The University of Hong Kong), along with an international Editorial Board of experts in the field.
Senior Editor Dr Bruix commented: “Liver cancer is a major health problem and a journal devoted to increase knowledge around it is sure to be an important development for the field.”
Hepatic Oncology publishes original research studies and reviews addressing preventive, diagnostic and therapeutic approaches to all types of cancer of the liver, in both the adult and pediatric populations. The journal also highlights significant advances in basic and translational research, and places them in context for future therapy.
Writing in the Foreword to the inaugural issue, Professor Finn and Dr Bruix stated: “The past decade has brought a robust amount of interest in liver cancer, spanning from bench research to the clinic in all aspects of liver tumor management. Our goal in the development of the journal is to provide a high-impact outlet for basic science, as well as all clinical aspects of liver oncology.”
Elisa Manzotti, Publisher of the Future Science Group journals, said, “We are delighted to announce the launch of our new journal Hepatic Oncology, which further strengthens our oncology portfolio. Effective cancer management continues to be one of the most pressing endeavors of medical research, and liver cancer in particular is becoming increasingly prevalent. We hope that our new title will provide a forum for the publication of innovative research findings and debate in this field.”